The use of Intraoperative Cell Salvage (ICS) in obstetrics has been slow to develop as a result of theoretical concerns relating to amniotic fluid embolism and fetal red cell contamination. In this article we examine the current UK position on the use of ICS in this clinical speciality and the recommendations for its safe and appropriate use.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/175045891102100801 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!